APA (7th ed.) Citation

MR, P., AM, Z., L, R., V, D., F, B., D, S., . . . B, C. (2014). Cirrhotic patients are still at risk of developing hepatocellular carcinoma despite Interferon-induced sustained virological response. European review for medical and pharmacological sciences, 18(2 Suppl), 11.

Chicago Style (17th ed.) Citation

MR, Pinzone, Zanghì AM, Rapisarda L, D'Agata V, Benanti F, Spartà D, Nunnari G, and Cacopardo B. "Cirrhotic Patients Are Still at Risk of Developing Hepatocellular Carcinoma Despite Interferon-induced Sustained Virological Response." European Review for Medical and Pharmacological Sciences 18, no. 2 Suppl (2014): 11.

MLA (9th ed.) Citation

MR, Pinzone, et al. "Cirrhotic Patients Are Still at Risk of Developing Hepatocellular Carcinoma Despite Interferon-induced Sustained Virological Response." European Review for Medical and Pharmacological Sciences, vol. 18, no. 2 Suppl, 2014, p. 11.